NCT02098278View on ClinicalTrials.gov

Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Lipoprotein Lipase Deficiency, FamilialHyperlipoproteinemia Type IChylomicronemia, FamilialHypertriglyceridemia
Interventions
DRUG

CAT-2003

DRUG

Placebo

Trial Locations (2)

G7H 7K9

Chicoutimi

G1V 4M6

Québec

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT02098278 - Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia | Biotech Hunter | Biotech Hunter